Skip to main content
Erschienen in: Inflammation 5/2014

01.10.2014

The Link Between Unpredictable Chronic Mild Stress Model for Depression and Vascular Inflammation?

verfasst von: Tuğçe Demirtaş, Tijen Utkan, Ayşe Karson, Yusufhan Yazır, Dilek Bayramgürler, Nejat Gacar

Erschienen in: Inflammation | Ausgabe 5/2014

Einloggen, um Zugang zu erhalten

Abstract

Inflammation has been suggested to be associated with stress-induced depression and cardiovascular dysfunction. Tumor necrosis factor alpha (TNF-α) is a major cytokine in the activation of neuroendocrine, immune, and behavioral responses. In this study, we investigated the effects of infliximab (a TNF-α inhibitor) on endothelium-dependent vascular reactivity, systemic blood pressure, and endothelial nitric oxide synthase (eNOS) immunoreactivity in the unpredictable chronic mild stress (UCMS) model of depression in rats. There was no significant change between all groups in the systemic blood pressure. In UCMS, endothelium-dependent relaxation of the smooth muscle in response to carbachol was significantly decreased with 50 % maximal response (E max) and pD2 values compared with the controls. Infliximab was able to reverse this UCMS effect. Relaxation in response to the nitric oxide (NO) donor sodium nitroprusside and papaverine and KCl-induced contractile responses was similar between groups. In UCMS, decreased expression of eNOS was detected. Moreover, there was no significant change in UCMS + infliximab group with respect to control rats. Our results suggest that tumor necrosis factor-alpha (TNF-α) could be a major mediator of vascular dysfunction associated with UCMS, leading to decreased expression of eNOS.
Literatur
1.
Zurück zum Zitat Black, P.H., and L.D. Garbutt. 2002. Stress, inflammation and cardiovascular disease. Journal of Psychosomatic Research 52: 1–23.PubMedCrossRef Black, P.H., and L.D. Garbutt. 2002. Stress, inflammation and cardiovascular disease. Journal of Psychosomatic Research 52: 1–23.PubMedCrossRef
2.
Zurück zum Zitat Strike, P.C., and A. Steptoe. 2004. Psychosocial factors in the development of coronary artery disease. Progress in Cardiovascular Diseases 46: 337–347.PubMedCrossRef Strike, P.C., and A. Steptoe. 2004. Psychosocial factors in the development of coronary artery disease. Progress in Cardiovascular Diseases 46: 337–347.PubMedCrossRef
3.
Zurück zum Zitat Naldi, L., and S.R. Mercuri. 2010. Epidemiology of comorbidities in psoriasis. Dermatologic Therapy 23: 114–118. Review.PubMedCrossRef Naldi, L., and S.R. Mercuri. 2010. Epidemiology of comorbidities in psoriasis. Dermatologic Therapy 23: 114–118. Review.PubMedCrossRef
4.
Zurück zum Zitat Michaud, K., and F. Wolfe. 2007. Comorbidities in rheumatoid arthritis. Best Practice & Research. Clinical Rheumatology 21: 885–906. Review.CrossRef Michaud, K., and F. Wolfe. 2007. Comorbidities in rheumatoid arthritis. Best Practice & Research. Clinical Rheumatology 21: 885–906. Review.CrossRef
5.
Zurück zum Zitat Mosovich, S.A., R.T. Boone, A. Reichenberg, S. Bansilal, J. Shaffer, K. Dahlman, P.D. Harvey, and M.E. Farkouh. 2008. New insights into the link between cardiovascular disease and depression. International Journal of Clinical Practice 62: 423–432. Review.PubMedCrossRef Mosovich, S.A., R.T. Boone, A. Reichenberg, S. Bansilal, J. Shaffer, K. Dahlman, P.D. Harvey, and M.E. Farkouh. 2008. New insights into the link between cardiovascular disease and depression. International Journal of Clinical Practice 62: 423–432. Review.PubMedCrossRef
6.
Zurück zum Zitat Lett, H.S., J. Davidson, and J.A. Blumenthal. 2005. Nonpharmacologic treatments for depression in patients with coronary heart disease. Psychosomatic Medicine 67(Suppl 1): S58–S62.PubMedCrossRef Lett, H.S., J. Davidson, and J.A. Blumenthal. 2005. Nonpharmacologic treatments for depression in patients with coronary heart disease. Psychosomatic Medicine 67(Suppl 1): S58–S62.PubMedCrossRef
7.
Zurück zum Zitat Plante, G.E. 2005. Depression and cardiovascular disease: a reciprocal relationship. Metabolism, Clinical and Experimental 54: 45–48. Review.CrossRef Plante, G.E. 2005. Depression and cardiovascular disease: a reciprocal relationship. Metabolism, Clinical and Experimental 54: 45–48. Review.CrossRef
8.
Zurück zum Zitat Howren, M.B., D.M. Lamkin, and J. Suls. 2009. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosomatic Medicine 71: 171–186.PubMedCrossRef Howren, M.B., D.M. Lamkin, and J. Suls. 2009. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosomatic Medicine 71: 171–186.PubMedCrossRef
9.
Zurück zum Zitat Dowlati, Y., N. Herrmann, W. Swardfager, H. Liu, L. Sham, E.K. Reim, and K.L. Lanctôt. 2010. A meta-analysis of cytokines in major depression. Biological Psychiatry 67: 446–457.PubMedCrossRef Dowlati, Y., N. Herrmann, W. Swardfager, H. Liu, L. Sham, E.K. Reim, and K.L. Lanctôt. 2010. A meta-analysis of cytokines in major depression. Biological Psychiatry 67: 446–457.PubMedCrossRef
10.
Zurück zum Zitat Pollak, Y., and R. Yirmiya. 2002. Cytokine-induced changes in mood and behaviour: implications for ‘depression due to a general medical condition’, immunotherapy and antidepressive treatment. International Journal of Neuropsychopharmacology 5: 389–399.PubMedCrossRef Pollak, Y., and R. Yirmiya. 2002. Cytokine-induced changes in mood and behaviour: implications for ‘depression due to a general medical condition’, immunotherapy and antidepressive treatment. International Journal of Neuropsychopharmacology 5: 389–399.PubMedCrossRef
11.
Zurück zum Zitat Capuron, L., and A.H. Miller. 2004. Cytokines and psychopathology: lessons from interferon-alpha. Biological Psychiatry 56: 819–824.PubMedCrossRef Capuron, L., and A.H. Miller. 2004. Cytokines and psychopathology: lessons from interferon-alpha. Biological Psychiatry 56: 819–824.PubMedCrossRef
12.
Zurück zum Zitat Willner, P., R. Muscat, and M. Papp. 1992. Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neuroscience and Biobehavioral Reviews 16: 525–534. Review.PubMedCrossRef Willner, P., R. Muscat, and M. Papp. 1992. Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neuroscience and Biobehavioral Reviews 16: 525–534. Review.PubMedCrossRef
13.
Zurück zum Zitat Willner, P. 1997. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology 134: 319–329.PubMedCrossRef Willner, P. 1997. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology 134: 319–329.PubMedCrossRef
14.
Zurück zum Zitat Willner, P. 2005. Chronic mild stress (CMS) revisited: consistency and behavioural neurobiological concordance in the effects of CMS. Neuropsychobiology 52: 90–110. Review.PubMedCrossRef Willner, P. 2005. Chronic mild stress (CMS) revisited: consistency and behavioural neurobiological concordance in the effects of CMS. Neuropsychobiology 52: 90–110. Review.PubMedCrossRef
15.
Zurück zum Zitat Karson, A., T. Demirtas, D. Bayramgürler, F. Balcı, and T. Utkan. 2013. Chronic administration of infliximab (TNF-alpha inhibitor) decreases depression and anxiety-like behaviour in rat model of chronic mild stress. Basic & Clinical Pharmacology & Toxicology 112(5): 335–340.CrossRef Karson, A., T. Demirtas, D. Bayramgürler, F. Balcı, and T. Utkan. 2013. Chronic administration of infliximab (TNF-alpha inhibitor) decreases depression and anxiety-like behaviour in rat model of chronic mild stress. Basic & Clinical Pharmacology & Toxicology 112(5): 335–340.CrossRef
16.
Zurück zum Zitat Yazir, Y., T. Utkan, and F. Aricioglu. 2012. Inhibition of neuronal nitric oxide synthase and soluble guanylate cyclase prevents depression-like behaviour in rats exposed to chronic unpredictable mild stress. Basic & Clinical Pharmacology & Toxicology 111(3): 154–160. Yazir, Y., T. Utkan, and F. Aricioglu. 2012. Inhibition of neuronal nitric oxide synthase and soluble guanylate cyclase prevents depression-like behaviour in rats exposed to chronic unpredictable mild stress. Basic & Clinical Pharmacology & Toxicology 111(3): 154–160.
17.
Zurück zum Zitat Bayramgurler, D., A. Karson, Y. Yazir, I.K. Celikyurt, S. Kurnaz, and T. Utkan. 2013. The effect of etanercept on aortic nitric oxide-dependent vasorelaxation in an unpredictable chronic mild stress model of depression in rats. European Journal of Pharmacology 710(1–3): 67–72.PubMedCrossRef Bayramgurler, D., A. Karson, Y. Yazir, I.K. Celikyurt, S. Kurnaz, and T. Utkan. 2013. The effect of etanercept on aortic nitric oxide-dependent vasorelaxation in an unpredictable chronic mild stress model of depression in rats. European Journal of Pharmacology 710(1–3): 67–72.PubMedCrossRef
18.
Zurück zum Zitat Behrendt, D., and P. Ganz. 2002. Endothelial function. From vascular biology to clinical applications. The American Journal of Cardiology 90: 40–48.CrossRef Behrendt, D., and P. Ganz. 2002. Endothelial function. From vascular biology to clinical applications. The American Journal of Cardiology 90: 40–48.CrossRef
19.
Zurück zum Zitat Broadly, A.J., A. Korszun, C.J. Jones, and M.P. Frenneaux. 2002. Arterial endothelial function is impaired in treated depression. Heart 88(5): 521–523.CrossRef Broadly, A.J., A. Korszun, C.J. Jones, and M.P. Frenneaux. 2002. Arterial endothelial function is impaired in treated depression. Heart 88(5): 521–523.CrossRef
20.
Zurück zum Zitat Rybakowski, J.K., A. Wykretowicz, A. Heymann-Szlachcinska, and H. Wysocki. 2006. Impairment of endothelial function in unipolar and bipolar depression. Biological Psychiatry 60(8): 889–891.PubMedCrossRef Rybakowski, J.K., A. Wykretowicz, A. Heymann-Szlachcinska, and H. Wysocki. 2006. Impairment of endothelial function in unipolar and bipolar depression. Biological Psychiatry 60(8): 889–891.PubMedCrossRef
21.
Zurück zum Zitat Le Mellédo, J.M., N. Mahil, and G.B. Baker. 2004. Nitric oxide: a key player in the relation between cardiovascular disease and major depressive disorder? Journal of Psychiatry & Neuroscience 29: 414–416. Le Mellédo, J.M., N. Mahil, and G.B. Baker. 2004. Nitric oxide: a key player in the relation between cardiovascular disease and major depressive disorder? Journal of Psychiatry & Neuroscience 29: 414–416.
22.
Zurück zum Zitat Chrapko, W.E., P. Jurasz, M.W. Radomski, N. Lara, S.L. Archer, and J.M. Le Mellédo. 2004. Decreased platelet nitric oxide synthase activity and plasma nitric oxide metabolites in major depressive disorder. Biological Psychiatry 15: 129–134.CrossRef Chrapko, W.E., P. Jurasz, M.W. Radomski, N. Lara, S.L. Archer, and J.M. Le Mellédo. 2004. Decreased platelet nitric oxide synthase activity and plasma nitric oxide metabolites in major depressive disorder. Biological Psychiatry 15: 129–134.CrossRef
23.
Zurück zum Zitat d’Audiffret, A.C., S.J. Frisbee, P.A. Stapleton, A.G. Goodwill, E. Isingrini, and J.C. Frisbee. 2010. Depressive behavior and vascular dysfunction: a link between clinical depression and vascular disease? Journal of Applied Physiology 108: 1041–1051.PubMedCrossRefPubMedCentral d’Audiffret, A.C., S.J. Frisbee, P.A. Stapleton, A.G. Goodwill, E. Isingrini, and J.C. Frisbee. 2010. Depressive behavior and vascular dysfunction: a link between clinical depression and vascular disease? Journal of Applied Physiology 108: 1041–1051.PubMedCrossRefPubMedCentral
24.
Zurück zum Zitat Isingrini, E., A. Surget, C. Belzung, J.L. Freslon, J. Frisbee, J. O’Donnell, V. Camus, and A. d’Audiffret. 2011. Altered aortic vascular reactivity in the unpredictable chronic mild stress model of depression in mice: UCMS causes relaxation impairment to ACh. Physiology & Behavior 103: 540–546.CrossRef Isingrini, E., A. Surget, C. Belzung, J.L. Freslon, J. Frisbee, J. O’Donnell, V. Camus, and A. d’Audiffret. 2011. Altered aortic vascular reactivity in the unpredictable chronic mild stress model of depression in mice: UCMS causes relaxation impairment to ACh. Physiology & Behavior 103: 540–546.CrossRef
25.
Zurück zum Zitat Isingrini, E., C. Belzung, J.L. Freslon, M.C. Machet, and V. Camus. 2012. Fluoxetine effect on aortic nitric oxide-dependent vasorelaxation in the unpredictable chronic mild stress model of depression in mice. Psychosomatic Medicine 74: 63–72.PubMedCrossRef Isingrini, E., C. Belzung, J.L. Freslon, M.C. Machet, and V. Camus. 2012. Fluoxetine effect on aortic nitric oxide-dependent vasorelaxation in the unpredictable chronic mild stress model of depression in mice. Psychosomatic Medicine 74: 63–72.PubMedCrossRef
26.
Zurück zum Zitat Nieuwdorp, M., M.C. Meuwese, H.L. Mooij, M.H. van Lieshout, A. Hayden, M. Levi, J.C. Meijers, C. Ince, J.J. Kastelein, H. Vink, and E.S. Stroes. 2009. Tumor necrosis factor-alpha inhibition protects against endotoxin-induced endothelial glycocalyx perturbation. Atherosclerosis 202(1): 296–303.PubMedCrossRef Nieuwdorp, M., M.C. Meuwese, H.L. Mooij, M.H. van Lieshout, A. Hayden, M. Levi, J.C. Meijers, C. Ince, J.J. Kastelein, H. Vink, and E.S. Stroes. 2009. Tumor necrosis factor-alpha inhibition protects against endotoxin-induced endothelial glycocalyx perturbation. Atherosclerosis 202(1): 296–303.PubMedCrossRef
27.
Zurück zum Zitat Arenas, I.A., Y. Xu, P. Lopez-Jaramillo, and S.T. Davidge. 2004. Angiotensin II-induced MMP-2 release from endothelial cells is mediated by TNF-alpha. American Journal of Physiology. Cell Physiology 286: 779–784.CrossRef Arenas, I.A., Y. Xu, P. Lopez-Jaramillo, and S.T. Davidge. 2004. Angiotensin II-induced MMP-2 release from endothelial cells is mediated by TNF-alpha. American Journal of Physiology. Cell Physiology 286: 779–784.CrossRef
28.
Zurück zum Zitat Yoshizumi, M., M.A. Perrella, J.C. Burnett, and M.E. Lee Jr. 1993. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circulation Research 73: 205–209.PubMedCrossRef Yoshizumi, M., M.A. Perrella, J.C. Burnett, and M.E. Lee Jr. 1993. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circulation Research 73: 205–209.PubMedCrossRef
29.
Zurück zum Zitat Lu, X.T., Y.F. Liu, L. Zhang, R.X. Yang, X.Q. Liu, F.F. Yan, Y.B. Wang, W.W. Bai, Y.X. Zhao, and F. Jiang. 2012. Unpredictable chronic mild stress promotes atherosclerosis in high cholesterol-fed rabbits. Psychosomatic Medicine 74: 604–611.PubMedCrossRef Lu, X.T., Y.F. Liu, L. Zhang, R.X. Yang, X.Q. Liu, F.F. Yan, Y.B. Wang, W.W. Bai, Y.X. Zhao, and F. Jiang. 2012. Unpredictable chronic mild stress promotes atherosclerosis in high cholesterol-fed rabbits. Psychosomatic Medicine 74: 604–611.PubMedCrossRef
30.
Zurück zum Zitat Furchgott, R.F., and J.V. Zawadzki. 1980. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288(5789): 373–376.PubMedCrossRef Furchgott, R.F., and J.V. Zawadzki. 1980. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288(5789): 373–376.PubMedCrossRef
31.
Zurück zum Zitat Ignarro, L.J., K.S. Wood, and M.S. Wolin. 1982. Activation of purified soluble guanylate cyclase by protoporphyrin IX. Proceedings of the National Academy of Sciences of the United States of America 79: 2870–2873.PubMedCrossRefPubMedCentral Ignarro, L.J., K.S. Wood, and M.S. Wolin. 1982. Activation of purified soluble guanylate cyclase by protoporphyrin IX. Proceedings of the National Academy of Sciences of the United States of America 79: 2870–2873.PubMedCrossRefPubMedCentral
32.
Zurück zum Zitat Grippo, A.J., J. Francis, T.G. Beltz, R.B. Felder, and A.K. Johnson. 2005. Neuroendocrine and cytokine profile of chronic mild stress-induced anhedonia. Physiology & Behavior 84: 697–706.CrossRef Grippo, A.J., J. Francis, T.G. Beltz, R.B. Felder, and A.K. Johnson. 2005. Neuroendocrine and cytokine profile of chronic mild stress-induced anhedonia. Physiology & Behavior 84: 697–706.CrossRef
33.
Zurück zum Zitat Csiszar, A., N. Labinskyy, K. Smith, A. Rivera, Z. Orosz, and Z. Ungvari. 2007. Vasculoprotective effects of anti-tumor necrosis factor-α treatment in aging. The American Journal of Pathology 170: 388–398.PubMedCrossRefPubMedCentral Csiszar, A., N. Labinskyy, K. Smith, A. Rivera, Z. Orosz, and Z. Ungvari. 2007. Vasculoprotective effects of anti-tumor necrosis factor-α treatment in aging. The American Journal of Pathology 170: 388–398.PubMedCrossRefPubMedCentral
34.
Zurück zum Zitat Hürlimann, D., A. Forster, G. Noll, F. Enseleit, R. Chenevard, O. Distler, M. Béchir, L.E. Spieker, M. Neidhart, B.A. Michel, R.E. Gay, T.F. Lüscher, S. Gay, and F. Ruschitzka. 2002. Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis. Circulation 106: 2184–2187.PubMedCrossRef Hürlimann, D., A. Forster, G. Noll, F. Enseleit, R. Chenevard, O. Distler, M. Béchir, L.E. Spieker, M. Neidhart, B.A. Michel, R.E. Gay, T.F. Lüscher, S. Gay, and F. Ruschitzka. 2002. Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis. Circulation 106: 2184–2187.PubMedCrossRef
35.
Zurück zum Zitat Fichtlscherer, S., L. Rössig, S. Breuer, M. Vasa, S. Dimmeler, and A.M. Zeiher. 2001. Tumor necrosis factor antagonism with etanercept improves systemic endothelial vasoreactivity in patients with advanced heart failure. Circulation 18: 3023–3025.CrossRef Fichtlscherer, S., L. Rössig, S. Breuer, M. Vasa, S. Dimmeler, and A.M. Zeiher. 2001. Tumor necrosis factor antagonism with etanercept improves systemic endothelial vasoreactivity in patients with advanced heart failure. Circulation 18: 3023–3025.CrossRef
36.
Zurück zum Zitat Yoshizumi, M., M.A. Perrella, J.C. Burnett, and M.E. Lee Jr. 1993. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circulation Research 73: 205–209.PubMedCrossRef Yoshizumi, M., M.A. Perrella, J.C. Burnett, and M.E. Lee Jr. 1993. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circulation Research 73: 205–209.PubMedCrossRef
37.
Zurück zum Zitat Murphy, H.S., J.A. Shayman, G.O. Till, M. Mahrougui, C.B. Owens, U.S. Ryan, and P.A. Ward. 1992. Superoxide responses of endothelial cells to C5a and TNF-α: divergent signal transduction pathways. The American Journal of Physiology 263: 51–59. Murphy, H.S., J.A. Shayman, G.O. Till, M. Mahrougui, C.B. Owens, U.S. Ryan, and P.A. Ward. 1992. Superoxide responses of endothelial cells to C5a and TNF-α: divergent signal transduction pathways. The American Journal of Physiology 263: 51–59.
38.
Zurück zum Zitat Tran, L.T., K.M. MacLeod, and J.H. McNeill. 2009. Chronic etanercept treatment prevents the development of hypertension in fructose-fed rats. Molecular and Cellular Biochemistry 330: 219–228.PubMedCrossRef Tran, L.T., K.M. MacLeod, and J.H. McNeill. 2009. Chronic etanercept treatment prevents the development of hypertension in fructose-fed rats. Molecular and Cellular Biochemistry 330: 219–228.PubMedCrossRef
Metadaten
Titel
The Link Between Unpredictable Chronic Mild Stress Model for Depression and Vascular Inflammation?
verfasst von
Tuğçe Demirtaş
Tijen Utkan
Ayşe Karson
Yusufhan Yazır
Dilek Bayramgürler
Nejat Gacar
Publikationsdatum
01.10.2014
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 5/2014
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-014-9867-4

Weitere Artikel der Ausgabe 5/2014

Inflammation 5/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.